Emmes CRO acquires Orphan Reach
Clinical Research Organization (CRO) Emmes, a portfolio company of Behrman Capital, announced it has acquired Orphan Reach, an organization specialized in clinical research related to rare diseases. Read More
Flare launches with $82M investment
Biotechnology company Flare Therapeutics announced it has launched with series A financing of $82 million. Read More
EBRC explains new ethics in engineering research statement
The Engineering Biology Research Consortium (EBRC) has published a companion paper to its Statement of Ethics in Engineering Biology Research. The new viewpoint paper was published in ACS Synthetic Biology on May 12. Read More
PerkinElmer to acquire Nexcelom for $260M
PerkinElmer has entered into an agreement to acquire life sciences instrumentation firm Nexcelom Bioscience for $260 million, a deal that is expected to be completed in the second quarter of 2021. Read More
Nuclera acquires E Ink unit, creates bioprinter
Nuclera has acquired E Ink's microfluidics unit, and, together, they have developed a desktop bioprinter that will be commercially available in 2022. Read More
X-Chem debuts OpenDEX software
X-Chem has announced the launch of its OpenDEX software, which offers access to DNA-encoded libraries and informatics tools offered in the company's drug discovery platform. Read More
VBI touts positive hepatitis B vaccine results
VBI Vaccines' prophylactic 3-antigen hepatitis B vaccine candidate offers better protection from the disease than the mono-antigenic vaccine Engerix-B, according to phase III study results. Read More
Cellectis, Sanofi partner on UCART clinical trials
Sanofi has agreed to supply anti-CD52 monoclonal antibody alemtuzumab for use in a lymphodepleting regimen in Cellectis-sponsored universal chimeric antigen receptor T-cell (UCART) trials. Read More
ERS Genomics, GenScript sign CRISPR/Cas9 license deal
ESR Genomics has agreed to nonexclusively license its CRISPR/Cas9 patent portfolio to GenScript. Read More
Sciex, Waters collaborate to offer fully integrated LC-MS systems
Sciex and Waters have inked a deal to provide integrated liquid chromatography and mass spectrometry (LC-MC) systems. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
